Dyslipoproteinaemia in postmenopausal women with a history of eclampsia

British Journal of Obstetrics and Gynaecology

Volumn 107, Issue 6, 2000, Pages 776-784

  Hubel, Carl A ^a   Snaedal, Sunna ^d   Ness, Roberta B ^a,b   Weissfeld, Lisa A ^b   Geirsson, Reynir T ^c   Roberts, James M ^a   Arngrímsson, Reynir ^d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^d UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN B; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; SIMVASTATIN; THIAZIDE DIURETIC AGENT;

ADULT; AGE; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DYSLIPOPROTEINEMIA; ECLAMPSIA; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; ICELAND; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PARITY; PHYSICAL EXAMINATION; POSTMENOPAUSE; PREGNANCY; PREGNANCY COMPLICATION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED STATES;

AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; ECLAMPSIA; FEMALE; HUMANS; HYPOLIPOPROTEINEMIAS; INSULIN; LIPIDS; LIPOPROTEINS, LDL; MIDDLE AGED; POSTMENOPAUSE; PREGNANCY; RISK FACTORS;

EID: 0034106188     PISSN: 03065456     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb13340.x     Document Type: Article

References (39)

1. 1 Roberts JM. Endothelial dysfunction in preeclampsia. Sem Reprod Endocrinol 1998; 16: 5-15.
2. 2 Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 1996; 175: 1365-1370.
3. 3 Sattar N, Bedomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 1997; 89: 403-408.
4. 4 Hubel CA. Dyslipidemia, iron, and oxidative stress in preeclampsia: assessment of maternal and feto-placental interactions. Semin Reprod Endocrinol 1998; 16: 75-92.
5. 5 Sowers JR, Saleh AA, Sokol RJ. Hyperinsulinemia and insulin resistance are associated with preeclampsia in African-Americans. Am J Hypertens. 1995; 8: 1-4.
6. 6 Lorentzen B, Birkeland KI, Endresen MJ, Henriksen T. Glucose intolerance in women with preeclampsia. Acta Obstet Gynecol Scand 1998; 77: 22-27.
7. 7 Kaaja R. Insulin resistance syndrome in preeclampsia. Sem Reprod Endocrinol 1998; 16: 41-46.
8. 8 Krauss RM. Atherogenicity of triglyceride-rich lipoproteins. Am J Cardiol 1998; 81 (4A): 13 B-17 B.
9. 9 Grundy SM. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 1998; 81 (4 A): 18 B-25 B.
10. 10 Lamarche B, Tchernof A, Mauriege P et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 1998; 279: 1955-1961.
11. 11 Hubel CA, Lyall F, Weissfeld L, Gandley RE, Roberts JM. Small low-density lipoproteins and vascular cell adhesion molecule (VCAM-1) are increased in association with hyperlipidemia in preeclampsia. Metabolism 1998; 47: 1281-1288.
12. 12 Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol 1996; 174: 975-982.
13. 13 Chait A, Brazg RL, Tribble DL, Krauss RM. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 1993; 94: 350-356.
14. 14 Jonsdottir LS, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995; 74:772-776.
15. 15 Sibai BM, El-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 1986; 155: 1011-1016.
16. 16 Chesley L, Annitto J, Cosgrove R. The remote prognosis of eclamptic women. Sixth periodic report. Am J Obstet Gynecol 1975; 124: 446-459.
17. 17 Chesley LC. Hypertension in pregnancy: definitions, familial factor, and remote prognosis. Kidney Internat 1980; 18: 234-240.
18. 18 Arngrimsson R, Geirsson RT, Bjornsson S, Bjornsson H, Walker JJ, Snaedal G. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol 1990; 97: 762-769.
19. 19 Sigfusson N, Sigvaldason H, Steingrimsdottir L, Gudmundsdottir I, Stefansdottir I, Thorsteinsson T. Decline in ischemic heart disease in Iceland and change in risk factor levels. BMJ 1991; 302: 1371-1375.
20. 20 Austin MA, Hokanson JE, Brunzell JD. Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Curr Opin Lipidol 1994; 5: 395-403.
21. 21 Li KM, Wilcken DEL, Dudman NPB. Effect of serum lipoprotein (a) on estimation of low-density lipoprotein cholesterol by the Friedwald formula. Clin Chem 1994; 40: 571-573.
22. 22 Hirany S, Li D, Jialal I. A more valid measurement of low-density lipoprotein cholesterol in diabetic patients. Am J Med 1997; 102: 48-53.
23. 23 Mann JI, Doll R, Thorogood M, Vessey MP, Waters WE. Risk factors for myocardial infarction in young women. Br J Prev Soc Med 1976; 30: 94-100.
24. 24 Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxaemia of pregnancy. Heart 1997; 77: 154-158.
25. 25 Reaven GM. Syndrome X: 6 years later. J Intern Med 1994; 236: 13-22.
26. 26 Laivuori H, Tikkanen MJ, Ylikorkala O. Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab 1996; 81:2908-2911.
27. 27 Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996; 276: 875-881.
28. 28 Stampfer MJ, Krauss RM, Ma J et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996; 276: 882-888.
29. 29 McNamara JR, Campos H, Ordovas JM, Peterson JH, Wilson PWF, Schaefer E. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Arteriosclerosis 1987; 7:483-490.
30. 30 Nikkila M, Pitkajarvi T, Koivula T et al. Women have a larger and less atherogenic low density lipoprotein particle size than men. Atherosclerosis 1996; 119: 181-190.
31. 31 Wagner A, Perez A, Calvo F, Bonet R, Castellvi A, Ordonez J. Apolipoprotein (B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients. Diabetes Care 1999; 22: 812-817.
32. 32 Campos H, Dreon DM, Krauss RM. Associations of hepatic and lipoprotein lipase activities with changes in dietary composition and low density lipoprotein subclasses. J Lipid Res 1995; 36: 462-472.
33. 33 Campos H, Walsh BW, Judge H, Sacks FM. Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metab 1997; 82: 3955-3963.
34. 34 Knopp RH, Zhu X. Multiple beneficial effects of estrogen on lipoprotein metabolism [editorial]. J Clin Endocrinol Metab 1997; 82: 3952-3954.
35. 35 Madu EC, Reddy RC, Madu AM, Anyaogu C, Harris T, Fraker TD. The effects of antihypertensive agents on serum lipids [review]. Am J Med Sci 1996; 312: 76-84.
36. 36 Sibai B, Mercer B, Sarinoglu C. Severe preeclampsia in the second semester: Recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991; 165: 1408-1412.
37. 37 Sibai BM, Gordon T, Thorn E et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. Am J Obstet Gynecol 1995; 172: 642-648.
38. 38 Adams EM, MacGillivray I. Long-term effect of pre-eclampsia on blood-pressure. Lancet 1961; 2: 1373-1375.
39. 39 Fisher KA, Lluger A, Spargo BH, Lindheimer MD. Hypertension in pregnancy: Clinical-pathological correlations and remote prognosis. Medicine 1981; 60: 267-276.